Eurobio Scientific SA
PAR:ALERS
Eurobio Scientific SA
PAR:ALERS
Price:
21.4
EUR
-4.46%
Market Closed
Market Cap:
€219.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Eurobio Scientific SA
PAR:ALERS
|
FR |
|
EDAG Engineering Group AG
XETRA:ED4
|
CH |
|
AI inside Inc
TSE:4488
|
JP |
|
Natco Pharma Ltd
NSE:NATCOPHARM
|
IN |
|
A
|
Amerisourcebergen Corp
LSE:0HF3
|
US |
|
Mori Trust Sogo Reit Inc
TSE:8961
|
JP |
|
Mirae ING Co Ltd
KRX:007120
|
KR |
|
Shenzhen King Brother Electronics Technology Co Ltd
SZSE:301041
|
CN |
|
M
|
MillerKnoll Inc
NASDAQ:MLKN
|
US |
|
Marvell Technology Inc
MIL:19MW
|
US |
|
Lydia Holding AS
IST:LYDHO.E
|
TR |
|
Access Co Ltd
TSE:4813
|
JP |
|
Soho China Ltd
HKEX:410
|
CN |
|
Shanghai Hanbell Precise Machinery Co Ltd
SZSE:002158
|
CN |
|
P
|
POSCO Thainox PCL
SET:INOX
|
TH |
|
Microport Scientific Corp
HKEX:853
|
CN |
|
Mechel PAO
MOEX:MTLR
|
RU |
|
Industria de Diseno Textil SA
MAD:ITX
|
ES |
|
Guangzhou Hexin Instrument Co Ltd
SSE:688622
|
CN |
|
S
|
Sachem Capital Corp
AMEX:SACH
|
US |
|
TAG Oil Ltd
XTSX:TAO
|
CA |
|
Victory Securities (Holdings) Company Ltd
HKEX:8540
|
HK |
|
F
|
Firebrick Pharma Ltd
ASX:FRE
|
AU |
|
Datametrex AI Ltd
XTSX:DM
|
CA |
Relative Value
The Relative Value of one
ALERS
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 21.4 EUR,
Eurobio Scientific SA
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ALERS Relative Value
HIDDEN
Multiples Across Competitors
ALERS Competitors Multiples
Eurobio Scientific SA Competitors
Eurobio Scientific SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| FR |
|
Eurobio Scientific SA
PAR:ALERS
|
215.5m EUR | 1.3 | 91.2 | 6.5 | 16.3 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.5B USD | 5.9 | 86.6 | 14.4 | 20 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
170.3B USD | 5.8 | 20 | 12.5 | 15.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.3B USD | 9.6 | 29.2 | 21.9 | 22.9 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.5B USD | 5.4 | 17.2 | 12.6 | 14.4 | |
| AU |
|
CSL Ltd
ASX:CSL
|
66.8B AUD | 3.1 | 34.3 | 11.3 | 14.3 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
41.3B USD | 11.1 | 131.9 | 73.8 | 82 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
